357 related articles for article (PubMed ID: 15265242)
21. Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A; Pereira B; Simonetta-Moreau M; Castelnovo G; De Verdal M; Fluchère F; Laurencin C; Degos B; Tir M; Kreisler A; Blanchet-Fourcade G; Guehl D; Colin O; Poujois A; Sangla S; Tatu L; Derost P; Gayraud D; Tranchant C; Amarantini D; Devos D; Rascol O; Corvol JC; Durif F; Rieu I;
N Engl J Med; 2023 Nov; 389(19):1753-1765. PubMed ID: 37937777
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Botulinum Toxin A in Children Undergoing Lower Limb Lengthening and Deformity Correction: Results of a Double-blind, Multicenter, Randomized Controlled Trial.
Hamdy RC; Montpetit K; Aiona MD; MacKenzie WG; van Bosse HJ; Narayanan U; Raney EM; Chafetz RS; Thomas SE; Weir S; Gregory S; Yorgova P; Takahashi S; Rinaldi M; Zhang X; Dahan-Oliel N
J Pediatr Orthop; 2016 Jan; 36(1):48-55. PubMed ID: 25730290
[TBL] [Abstract][Full Text] [Related]
23. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
24. Treating severe bruxism with botulinum toxin.
Tan EK; Jankovic J
J Am Dent Assoc; 2000 Feb; 131(2):211-6. PubMed ID: 10680389
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
[TBL] [Abstract][Full Text] [Related]
26. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
Porta M
Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.
Defazio G; Abbruzzese G; Girlanda P; Vacca L; Currà A; De Salvia R; Marchese R; Raineri R; Roselli F; Livrea P; Berardelli A
Arch Neurol; 2002 Mar; 59(3):418-20. PubMed ID: 11890846
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
Morra ME; Elgebaly A; Elmaraezy A; Khalil AM; Altibi AM; Vu TL; Mostafa MR; Huy NT; Hirayama K
J Headache Pain; 2016 Dec; 17(1):63. PubMed ID: 27377706
[TBL] [Abstract][Full Text] [Related]
29. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis.
Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM
J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934
[TBL] [Abstract][Full Text] [Related]
30. Unclear results for the use of botulinum toxin therapy for TMD pain.
Keenan JR
Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526
[TBL] [Abstract][Full Text] [Related]
31. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
Sherif H; Khalil M; Omar R
Can J Urol; 2017 Jun; 24(3):8838-8846. PubMed ID: 28646940
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of botulinum toxin sphincteric injections in the treatment of incomplete voiding after spinal cord injury.
Mehta S; Hill D; Foley N; Hsieh J; Ethans K; Potter P; Baverstock R; Teasell RW; Wolfe D;
Arch Phys Med Rehabil; 2012 Apr; 93(4):597-603. PubMed ID: 22365478
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of anal fissures with botulinum toxin].
Wollina U
Zentralbl Chir; 2008 Apr; 133(2):123-8. PubMed ID: 18415898
[TBL] [Abstract][Full Text] [Related]
34. Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis.
Galvin R; Callaghan C; Chan WS; Dimitrov BD; Fahey T
Semin Arthritis Rheum; 2011 Jun; 40(6):585-7. PubMed ID: 21397930
[No Abstract] [Full Text] [Related]
35. Safety of Botulinum Toxin A Injections for Facial Rejuvenation: A Meta-Analysis of 9,669 Patients.
Gostimir M; Liou V; Yoon MK
Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):13-25. PubMed ID: 35353777
[TBL] [Abstract][Full Text] [Related]
36. Review of botulinum toxin type A and its clinical applications in migraine headache.
Silberstein SD
Expert Opin Pharmacother; 2001 Oct; 2(10):1649-54. PubMed ID: 11825307
[TBL] [Abstract][Full Text] [Related]
37. Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review.
Intiso D; Santamato A; Di Rienzo F
Disabil Rehabil; 2017 Oct; 39(21):2123-2133. PubMed ID: 27764971
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
39. The Effectiveness and Safety of Botulinum Toxin Injections for the Treatment of Congenital Muscular Torticollis.
Qiu X; Cui Z; Tang G; Deng H; Xiong Z; Han S; Tang S
J Craniofac Surg; 2020; 31(8):2160-2166. PubMed ID: 33136847
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
